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STATE-OF-THE-ART PAPER STATE-OF-THE-ART PAPER1309Microvolt T-Wave AlternansRichard L. Verrier, Thomas Klingenheben, Marek Malik Nabil El-Sherif, Derek V. Exner,
Stefan H. Hohnloser, Takanori Ikeda, Juan Pablo Martı´nez, Sanjiv M. Narayan, Tuomo Nieminen,
David S. Rosenbaum
This consensus guideline discusses the electrocardiographic phenomenon of T-wave alternans
(TWA), which is the beat-to-beat alternation in the morphology and amplitude of the
ST-segment or T-wave. This statement focuses on its physiologic basis, measurement
technologies, and clinical utility. Several different measurement techniques have been used,
and there is strong evidence that TWA can identify patients at increased risk for
cardiovascular mortality and for sudden cardiac death. However, interventional studies for
guiding the use of implantable defibrillators have been negative. Further research is needed to
determine the role of TWA in guiding therapy.CLINICAL RESEARCH INTERVENTIONAL CARDIOLOGY
1325No Difference Seen Between Biodegradable and
Permanent Polymer Stents at 3 YearsRobert A. Byrne, Adnan Kastrati, Steffen Massberg, Anna Wieczorek, Karl-Ludwig Laugwitz,
Martin Hadamitzky, Stefanie Schulz, Jürgen Pache, Massimiliano Fusaro, Jörg Hausleiter, Albert Schömig,
Julinda Mehilli, for the ISAR-TEST 4 Investigators
Byrne and colleagues hypothesized that the polymer that binds the drug to drug-eluting
stents (DES) may cause inflammation and increase long-term rates of restenosis and
thrombosis. In the ISAR-TEST 4 (Intracoronary Stenting and Angiographic Results:
Test Efficacy of 3 Limus-Eluting Stents 4) trial, 2,600 patients were randomized to either a
biodegradable polymer (BP) DES or the standard permanent polymer (PP) stent. In addition,
those randomized to PP were randomized again to either everolimus-eluting stents (EES) or
sirolimus-eluting stents (SES). Overall, there was no significant difference between BP and
PP for cardiac death, target vessel-related myocardial infarction, or target lesion
revascularization at 3 years. The endpoints were also similar between EES and SES.(continued on page A-19)
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1332Undetectable Troponin on High-Sensitivity Assay
Excludes MI in Patients With Chest PainRichard Body, Simon Carley, Garry McDowell, Allan S. Jaffe, Michael France, Kennedy Cruickshank,
Christopher Wibberley, Michelle Nuttall, Kevin Mackway-Jones
Body and colleagues noticed that in a previous study of biomarkers for patients presenting
with chest pain, no patient with an undetectable result with a high-sensitivity cardiac
troponin T (hs-cTnT) test went on to be diagnosed with an acute myocardial infarction
(AMI), so they designed a prospective study. A total of 18% of patients had a confirmed
AMI, none of whom had initially undetectable hs-cTnT (negative predictive value [NPV]
100%). This strategy would “rule out” AMI in 28% of patients, and only 2 (1.0%) of these
patients died or had an AMI within 6 months (1 periprocedural AMI in a patient with stable
angina and 1 noncardiac death). In an additional 915 patients in clinical practice, only 1
patient (0.6%) with initially undetectable hs-cTnT developed subsequent elevation (NPV
99.4%). Undetectable hs-cTnT at presentation has a very high NPV for ruling out AMI and
may identify patients at low risk with early discharge.Editorial Comment: W. Frank Peacock, p. 1340HEART FAILURE1343Risk of HF in Obese Individuals Is Related to Metabolic SyndromeChristina Voulgari, Nicholas Tentolouris, Polychronis Dilaveris, Dimitris Tousoulis, Nicholas Katsilambros,
Christodoulos Stefanadis
Obesity has frequently been associated with an increased risk of heart failure (HF). Voulgari
and colleagues investigated the link further by studying the relationships between obesity,
metabolic syndrome (MetS), and the risk of heart failure. A total of 550 participants were
classified by presence or absence of MetS and by body mass index (BMI). BMI was not
associated with increased HF risk, but MetS conferred a 2.5-fold higher HF risk. Obese
individuals without MetS had the lowest 6-year HF risk. These results show that MetS,
rather than obesity, increases the risk of HF.
Editorial Comment: Eileen Hsich, p. 1351(continued on page A-20)
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mHEART FAILURE1353Isolated Quadriceps Training Increases Maximal Exercise Capacity in CHFFabio Esposito, Van Reese, Ralph Shabetai, Peter D. Wagner, Russell S. Richardson
Esposito and colleagues studied muscle structure and oxygen (O2) transport and metabolism
n patients with chronic heart failure (CHF) before and after a structured exercise program
esigned to increase quadriceps strength. Pre-training cycling and knee-extensor (KE) peak
eg O2 uptake (VO2peak) were 17% and 15% lower, respectively, in subjects with CHF
ompared with controls. KE training increased quadriceps muscle capillarity and
itochondrial density. Despite not altering maximal cardiac output, KE training increased
aximal O2 delivery and arterial-venous O2 difference. These results suggest that isolated
uscle training can improve exercise tolerance in patients with CHF by improving peripheral
uscle O2 utilization.HEART RHYTHM DISORDERS
1363Percutaneous LVAD May Stabilize Patients
for Mapping Hemodynamically Unstable VTMarc A. Miller, Srinivas R. Dukkipati, Alexander J. Mittnacht, Jason S. Chinitz, Lynn Belliveau,
Jacob S. Koruth, J. Anthony Gomes, Andre d’Avila, Vivek Y. Reddy
Miller and colleagues investigated the utility of using a percutaneous left ventricular assist
device (pLVAD) to hemodynamically support patients during catheter ablation of unstable
ventricular tachycardia (VT). Twenty-three consecutive procedures in patients with structural
heart disease and hemodynamically unstable VT were performed with either pLVAD support
or no pLVAD support (intra-aortic balloon pump counterpulsation: n  6, or no support:
n  7) at operator discretion. The pLVAD group was maintained in VT significantly longer
than the non-pLVAD group and required fewer early terminations of sustained VT for
hemodynamic instability. In patients with scar-related VT undergoing catheter ablation,
pLVAD may increase the time available to properly map and ablate the malignant substrate.CARDIAC IMAGING1372Prevalence of MRI-Detected Unrecognized MI and Cerebral Ischemic LesionsCharlotte Ebeling Barbier, Ruta Nylander, Raquel Themudo, Håkan Ahlström, Lars Lind,
Elna-Marie Larsson, Tomas Bjerner, Lars Johansson
Ebeling Barbier and colleagues investigated the prevalence of myocardial infarction (MI)
detected with magnetic resonance imaging (MRI) and cerebral ischemic lesions on MRI in
an elderly population-based cohort. Clinically unrecognized myocardial infarctions (UMIs)
were found in 30% of subjects, and previously recognized myocardial infarctions (RMIs) were
found in 5%. The prevalence of both types of MI was higher in men than in women. Men
with RMI were more likely to have evidence of cortical and lacunar cerebral infarctions,
whereas women with UMI more frequently had cortical cerebral infarctions. This study shows
a surprisingly high rate of UMIs detected by cardiac MRI and that these typically male
patients are also likely to have previously suffered a stroke.(continued on page A-24)
SEPTEMBER 20, 2011 (continued) A-24CARDIOVASCULAR RISK1378Meta-Analysis Confirms Link Between ED and Cardiovascular RiskJia-Yi Dong, Yong-Hong Zhang, Li-Qiang Qin
Dong and colleagues evaluated the association between erectile dysfunction (ED) and the risk
of cardiovascular disease (CVD) and mortality by conducting a meta-analysis. Twelve
prospective cohort studies involving 36,744 participants were included in the meta-analysis.
The overall combined relative risk for men with ED compared with the reference group was
1.48 for CVD, 1.35 for stroke, and 1.19 for all-cause mortality. Sensitivity analysis restricted
to studies with control for conventional cardiovascular risk factors yielded similar results. This
meta-analysis suggests that ED is a marker of increased CVD risk independent of
conventional cardiovascular risk factors.CARDIOVASCULAR RISK1386Evidence That PAD Is HeritableChristina L. Wassel, Rohit Loomba, Joachim H. Ix, Matthew A. Allison, Julie O. Denenberg,
Michael H. Criqui
While peripheral artery disease (PAD) likely results from both genetic and environmental
factors, the influence of a family history of PAD on subsequent risk has not been adequately
investigated. Wassel and colleagues reviewed data collected for the SDPS (San Diego
Population Study). The prevalence of PAD was 3.6%, and severe PAD was found in 1.9% of
patients. In fully-adjusted models, a family history of PAD was associated with a 1.83-fold
higher odds of PAD, an association that was even stronger for severe prevalent PAD (odds
ratio: 2.42). These results confirm that a family history of PAD is independently associated
with PAD prevalence and severity.
